Saturday 17 October 2026
Export TNDM’s income statement to Excel — free account
Tandem Diabetes Care, Inc.
TNDM Healthcare Medical Devices
Tandem Diabetes Care, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 7.93% from fiscal 2024. In the quarter to June 2026, revenue grew 5.77%, EPS grew 60.3%, free cash flow fell 146.3% and total debt rose 94.9%, each against the same quarter a year earlier.
16.17
0.35
−2.12%
Follow TNDM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(109.73%) | (97.88%) | (65.73%) | (48.03%) | |
Piotroski F-Score |
3 | 3 | 5 | 4 | |
| (22.20%) | (22.15%) | (9.11%) | (6.24%) | ||
ROIC |
(99.30%) | (67.83%) | (31.96%) | (10.33%) | |
Return on Tangible Assets |
(45.98%) | (44.60%) | (13.09%) | (9.95%) | |
Average Days of Receivables |
45.65 | 59.53 | 49.97 | 56.80 | |
Free Cash Flow per Share |
(0.37) | (0.44) | (0.05) | (0.39) | |
Free Cash Flow |
(25.12) | (29.67) | (3.64) | (26.62) | |
Capital Expenditures |
(16.33) | (19.95) | (23.25) | (21.09) | |
| Other line items | |||||
Cash ROIC |
(3.30%) | (3.91%) | (0.28%) | (2.24%) | |
Accounts Receivable Turnover |
8.64 | 7.25 | 7.69 | 7.17 | |
Accounts Payable Turnover |
9.79 | 10.21 | 7.74 | 7.64 | |
Inventory Turnover |
3.25 | 3.37 | 3.46 | 3.30 | |
Average Days of Payables |
36.80 | 36.65 | 47.18 | 51.10 | |
Days of Inventory on Hand |
106.39 | 100.27 | 99.62 | 107.65 | |
Tax Rate |
(0.01) | 0.02 | (0.04) | 0.04 | |
Research and Development Expense of Revenue |
27.26% | 26.44% | 18.39% | 18.03% | |
Selling, General and Administrative Expense of Revenue |
43.47% | 43.85% | 42.76% | 42.38% | |
Share Based Compensation of Revenue |
9.97% | 9.10% | 8.03% | 6.98% | |
Interest Coverage |
(25.50) | (23.68) | (10.16) | (5.21) | |
Operating CF/Net income |
0.04 | 0.05 | (0.21) | 0.09 | |
Depreciation/Fixed assets |
0.20 | 0.19 | 0.20 | 0.19 | |
Capex/Depreciation |
(1.05) | (1.27) | (1.42) | (1.29) | |
Revenue per Share |
14.89 | 15.08 | 15.02 | 15.09 | |
Operating CF per Share |
(0.13) | (0.14) | 0.29 | (0.08) | |
Capex per Share |
(0.24) | (0.30) | (0.34) | (0.31) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates